InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Satvat Ali J.. Director active across 2 companies, notably BridgeBio Pharma, Inc.. In total, 6 filings have been recorded. History available since 30 December 2024. The latest transaction was disclosed on 5 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Satvat Ali J. is a declarant linked to BridgeBio Pharma, Inc. and Coherus Oncology, Inc., where the listed role is Director. The record shows 6 filings in total, and the sampled filings run from 2024-12-31 to 2026-06-24. The sampled transactions are of Attribution nature, with top filing amounts of EUR 1001492.854589783, EUR 839863.1416971934, and EUR 637348.3714062414.